$2.48T
Total marketcap
$58.97B
Total volume
BTC 50.55%     ETH 15.18%
Dominance

Myrexis MYRX Stock

0.01 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
4.14M USD
LOW - HIGH [24H]
0.01 - 0.01 USD
VOLUME [24H]
2 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 USD

Myrexis Price Chart

Myrexis MYRX Financial and Trading Overview

Myrexis stock price 0.01 USD
Previous Close 0.0018 USD
Open 0.0018 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0018 - 0.0018 USD
52 Week Range 0.0004 - 0.0018 USD
Volume 25 USD
Avg. Volume 27 USD
Market Cap 4.14M USD
Beta (5Y Monthly) 2.620774
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date February 19, 2013
1y Target Est N/A

MYRX Valuation Measures

Enterprise Value -1147937 USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.052941173
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.106

Trading Information

Myrexis Stock Price History

Beta (5Y Monthly) 2.620774
52-Week Change 350.00%
S&P500 52-Week Change 20.43%
52 Week High 0.0018 USD
52 Week Low 0.0004 USD
50-Day Moving Average 0.00169 USD
200-Day Moving Average 0.000937 USD

MYRX Share Statistics

Avg. Volume (3 month) 27 USD
Avg. Daily Volume (10-Days) 56 USD
Shares Outstanding 34.48M
Float N/A
Short Ratio 0.39
% Held by Insiders 0%
% Held by Institutions 1.25%
Shares Short 48.45K
Short % of Float 0.18%
Short % of Shares Outstanding 0.18%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2013
Most Recent Quarter (mrq) June 30, 2013
Next Fiscal Year End June 30, 2014

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -15.060%
Return on Equity (ttm) -25.67%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -10805000 USD
Net Income Avi to Common (ttm) -11621000 USD
Diluted EPS (ttm) -0.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.21M USD
Total Cash Per Share (mrq) 0.04 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 16.716
Book Value Per Share (mrq) 0.034

Cash Flow Statement

Operating Cash Flow (ttm) -12972000 USD
Levered Free Cash Flow (ttm) -7309000 USD

Profile of Myrexis

Country United States
State NY
City New York
Address 630 Fifth Avenue
ZIP 10020
Phone 801-214-7800
Website https://www.myrexis.com
Industry Shell Companies
Sector(s) Financial Services
Full Time Employees 1

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Q&A For Myrexis Stock

What is a current MYRX stock price?

Myrexis MYRX stock price today per share is 0.01 USD.

How to purchase Myrexis stock?

You can buy MYRX shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Myrexis?

The stock symbol or ticker of Myrexis is MYRX.

Which industry does the Myrexis company belong to?

The Myrexis industry is Shell Companies.

How many shares does Myrexis have in circulation?

The max supply of Myrexis shares is 394.05M.

What is Myrexis Price to Earnings Ratio (PE Ratio)?

Myrexis PE Ratio is now.

What was Myrexis earnings per share over the trailing 12 months (TTM)?

Myrexis EPS is -0.03 USD over the trailing 12 months.

Which sector does the Myrexis company belong to?

The Myrexis sector is Financial Services.